Navigation Links
Drug Company Halts Late-Stage Trial of Sickle-Cell Disease Drug

Drug manufacturer Icagen announced that it has ended its Phase III clinical trial of its sickle-cell treatment senicapoc, citing lack of effectiveness//, the Raleigh News & Observer reports.

Sickle-cell disease is a genetic blood disorder primarily affecting blacks, but can also be found Hispanics and people from the Middle East, Southeast Asia and the Mediterranean region.

Final testing in the 160-participant senicapoc study began in February 2005, and concerns about the treatment's effectiveness arose in August 2006 after the study's data monitoring committee suggested that senicapoc likely would benefit only a small number of people.

Icagen and Johnson & Johnson -- which paid $15 million to market and help develop the drug -- at that point decided to adjust the number of participants and treatment options being tested in the trial.

Recently, the committee said preliminary trial data show that senicapoc does not prevent chronic pain, one of the disease's most prominent complications. However, the drug consistently has been able to reduce the number of deformed blood cells associated with the disease. That effect "might make the drug suitable to reduce elevated blood pressure in the lungs of some sickle-cell patients and the stroke risk for pediatric sickle-cell patients," according to the News & Observer.

Currently, there is only one other treatment available for the disease. Richard Katz, Icagen's senior vice president of finance and corporate development, said that despite the findings, "it would be premature to say senicapoc is dead." He said the drug's future should be clearer in a few months.

Source-Kaiser Family Foundation/M
'"/>




Page: 1

Related medicine news :

1. Problems Of a Growing Company
2. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Elderly People Prefer The Company Of Pet Dogs
5. Ossur Acquires the U.S. Orthopaedics Company
6. Britain Approves Indian Company For Supplying Medicines
7. Drug Company Admits Knowledge Of Side Effects In Monkeys
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. Indian Training Company To Train Children In Dubai, Sharjah
10. GE Healthcare to Acquire Swedish Medical Company
11. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... June 23, 2016 The vast majority of ... dialysis facility.  Treatments are usually 3 times a week, ... visit, including travel time, equipment preparation and wait time. ... especially grueling for patients who are elderly and frail.  ... nursing and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: